Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Glenmark Pharmaceuticals Limited
Press Release Feb 16 2021
Published Feb 16 2021
5 min read

Press Release Feb 16 2021

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 16, 2021, titled "Glenmark launches SUTIB (Sunitinib) priced 96% lower than the innovator brand. Reduces the risk of kidney cancer progression by 58%".

View Attachment